Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
Warning: file_get_contents(http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=15746175&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 445
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Nanomedicine: current status and future prospects Moghimi SM; Hunter AC; Murray JCFASEB J 2005[Mar]; 19 (3): 311-30Applications of nanotechnology for treatment, diagnosis, monitoring, and control of biological systems has recently been referred to as "nanomedicine" by the National Institutes of Health. Research into the rational delivery and targeting of pharmaceutical, therapeutic, and diagnostic agents is at the forefront of projects in nanomedicine. These involve the identification of precise targets (cells and receptors) related to specific clinical conditions and choice of the appropriate nanocarriers to achieve the required responses while minimizing the side effects. Mononuclear phagocytes, dendritic cells, endothelial cells, and cancers (tumor cells, as well as tumor neovasculature) are key targets. Today, nanotechnology and nanoscience approaches to particle design and formulation are beginning to expand the market for many drugs and are forming the basis for a highly profitable niche within the industry, but some predicted benefits are hyped. This article will highlight rational approaches in design and surface engineering of nanoscale vehicles and entities for site-specific drug delivery and medical imaging after parenteral administration. Potential pitfalls or side effects associated with nanoparticles are also discussed.|Blood Vessels[MESH]|Diagnosis[MESH]|Drug Administration Routes[MESH]|Drug Delivery Systems[MESH]|Drug Hypersensitivity[MESH]|Drug Industry[MESH]|Drug Therapy[MESH]|Drug-Related Side Effects and Adverse Reactions[MESH]|Endothelium, Vascular[MESH]|Humans[MESH]|Lymphatic System[MESH]|Macrophages/immunology/physiology[MESH]|Microscopy, Electron, Scanning[MESH]|Nanostructures/adverse effects[MESH]|Nanotechnology/*trends[MESH]|National Institutes of Health (U.S.)[MESH]|Neoplasms/drug therapy[MESH]|Particle Size[MESH]|Technology, Pharmaceutical[MESH]|United States[MESH] |
